Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.
about
Molecular pathology of lung cancer: key to personalized medicine.MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.Modeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expressionThe intersection between DNA damage response and cell death pathwaysRelationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancerEpidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma.The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cellsChloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.Bioactive properties and clinical safety of a novel milk protein peptide.PUMA and BIM are required for oncogene inactivation-induced apoptosis.Differential effect of grape seed extract against human non-small-cell lung cancer cells: the role of reactive oxygen species and apoptosis induction.Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: molecular and clinical aspects.Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung.Fisetin, a dietary phytochemical, overcomes Erlotinib-resistance of lung adenocarcinoma cells through inhibition of MAPK and AKT pathways.Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.BIRC5 expression is a poor prognostic marker in Ewing sarcoma.MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcomaDown-Regulation of Survivin by Nemadipine-A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis.Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells.Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment.Survivin mRNA expression in blood as a predictor of the response to EGFR-tyrosine kinase inhibitors and prognosis in patients with non-small cell lung cancer.Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling
P2860
Q27691299-BFD3EF80-1EA0-41B0-B41F-CE24676372ADQ27853222-B7329718-1A91-4C8D-A474-4F48D1AE8355Q28484612-673E416C-9246-48D8-941F-A20907E64FD9Q28611423-A5C5F21D-E243-44EE-9C29-886F180E2EAEQ33818958-4AA29E4D-BE7E-45A2-BEE1-5F641AB0617DQ33947130-F2CDEFF7-1C5A-408F-9491-A1417FDB7B28Q35068059-09A71B51-5876-4F67-94BC-37C0137D49E1Q35217204-C37E6BD8-0D28-48E2-945E-B0818C6A3B44Q35386537-6E4E2F65-403C-4179-8977-382B4A113BF2Q37121933-1EEBB62E-459C-4F3A-907C-36AB80662AB8Q37383943-3FB4F338-50B8-40A1-A86D-9444B623C6DBQ38008456-CD707550-43EA-4798-BEA6-5C8F29B32FAAQ38390024-4381648A-9057-42E2-BE6C-9606C9675EFDQ38728165-FD39B283-17A3-4721-8FA3-0036486F222CQ38779461-55EE7BDF-1D5F-4CA8-94CE-96A8E278643AQ39282601-B14F5197-61D7-4F24-B58C-82D5D8797F60Q39447204-93899A0D-5E6A-4B2B-B552-89B6FC04A707Q40978522-7491CC3B-FDE5-456F-B7C5-ED98A53825BBQ40996325-0ED6FD44-8D3B-4215-9576-6C2AEBF2A306Q41813491-3F069EF1-C24C-42F0-AE79-B41653744B1FQ44655459-C98571CE-99E1-4FF6-B1BB-C86F52CAB999Q45139318-B17B14E9-4BB8-4960-B52E-40D26B3B714CQ45278609-EBB8FED7-96EF-4B91-8670-E501D6122B1EQ47754114-4FAF85A6-F4E8-430D-93B4-BBE3AB3DB95FQ50060950-E15C82A4-5012-41B9-A10C-3E66BECFA164Q54356882-C6507F76-002B-443B-9D9D-6161B13CFE29Q54375452-8C568A0F-975D-4046-98E1-EE4C245AA248Q58802947-465EBA7B-1190-40B6-93FE-5E605F00222B
P2860
Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@en
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@nl
type
label
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@en
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@nl
prefLabel
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@en
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@nl
P2093
P1433
P1476
Role of survivin in EGFR inhib ...... s positive for EGFR mutations.
@en
P2093
Haruka Yamaguchi
Isamu Okamoto
Kaoru Tanaka
Kazuhiko Nakagawa
Kazuto Nishio
Ken Takezawa
Kiyoko Kuwata
Kunio Okamoto
Wataru Okamoto
P304
10402-10410
P356
10.1158/0008-5472.CAN-10-2438
P407
P577
2010-12-01T00:00:00Z